CD8A and neoplasm: The treatment with the IL-12 gene in an experimental HPV16-positive mouse tumor model showed an antitumor effect promoting the cellular immune response via shift to a Th1-cytokine profile (activation of CD8+ T cells and Natural killer (NK) T cells that can eliminate tumor cells).